John Tabone
Oncology
Stratos Genomics
United States of America
Biography
25+ years in a startup environment developing innovative technologies in the areas of nucleoside chemistry, molecular diagnostics, genomic measurement, and high throughput automation of oligonucleotide and gene synthesis. Dr. Tabone led design and implementation of a highly automated scalable gene manufacturing platform for a leading US gene synthesis company, Blue Heron Biotech. While at Microprobe he managed the late stage development and manufacture of a 510k-approved DNA diagnostic. He was an inventor of the CMST SNP mass spectrometry-based measurement technology and led its development through to an early commercial stage. Previous positions include Vice President of Technology Development at Blue Heron Biotechnology, Inc., Director of Technology Development at Rapigene, Inc., Senior Scientist at Darwin Molecular Corporation, Senior Scientist / Manager Microprobe Corporation. Dr. Tabone has been an inventor or co-inventor on 23 issued US patents. He received a B.S. in Chemistry from St. John’s University and a Ph.D. in Medicinal Chemistry from the University of Minnesota, Minneapolis.
Research Interest
Oncology